The anti-melanoma effects of CRO15 were also confirmed in a more physiological model of melanoma cell cultures freshly isolated from patient tumors with BRAF mutation (Patient 1), NRAS mutation (Patients 2 and 3), PTEN and p53 mutations (Patient 4) and with no know mutation (Patient 5). Here, NRAS is linked to melanoma.